INDIGO Home University of Illinois at Urbana-Champaign logo uic building uic pavilion uic student center

Regulation and functional significance of CDC42 alternative splicing in ovarian cancer.

Show simple item record

Bookmark or cite this item: http://hdl.handle.net/10027/20779

Files in this item

File Description Format
PDF Regulation and functional significance.pdf (5MB) Main Article PDF
Title: Regulation and functional significance of CDC42 alternative splicing in ovarian cancer.
Author(s): He, X; Yuan, C; Yang, J
Subject(s): CDC42 PTBP1 alternative splicing ovarian cancer
Abstract: Our previous study found that splicing factor polypyrimidine tract-binding protein 1 (PTBP1) had a role in tumorigenesis but the underlying mechanism remained unclear. In this study, we observed that knockdown of PTBP1 inhibited filopodia formation. Subsequently, we found that PTBP1 regulated the alternative splicing of CDC42, a major regulator of filopodia formation. Two CDC42 variants, CDC42-v1 and CDC42-v2, can be generated through alternative splicing. Knockdown of PTBP1 increased the expression of CDC42-v2. Ectopic expression of individual variants showed that CDC42-v2 suppressed filopodia formation, opposite to the effect of CDC42-v1. Quantitative RT-PCR revealed that CDC42-v2 was expressed at lower levels in ovarian cancer cell lines and ovarian tumor tissues than in normal control cells and tissues. Further, CDC42-v2 was observed to have inhibitory effects on ovarian tumor cell growth, colony formation in soft agar and invasiveness. In contrast, these inhibitory effects were not found with CDC42-v1. Taken together, above results suggest that the role of PTBP1 in tumorigenesis may be partly mediated by its regulation of CDC42 alternative splicing and CDC42-v2 might function as a tumor suppressor.
Issue Date: 2015-10-06
Publisher: Impact Journals
Citation Info: He, X., Yuan, C. and Yang, J. Regulation and functional significance of CDC42 alternative splicing in ovarian cancer. Oncotarget. 2015. 6(30): 29651-29663. DOI: 10.18632/oncotarget.4865.
Type: Article
Description: This is a copy of an article published in Oncotarget © 2015 Impact Journals Publications.
URI: http://hdl.handle.net/10027/20779
Sponsor: This work was supported in part by a grant from American Cancer Society, Illinois Division (to Xiaolong He, grant # 245461) and in part by the Vahlteich Research Award from College of Pharmacy, University of Illinois at Chicago (to Xiaolong He).
Date Available in INDIGO: 2016-06-20
 

This item appears in the following Collection(s)

Show simple item record

Statistics

Country Code Views
United States of America 82
China 42
Russian Federation 22
Germany 6
Ukraine 6

Browse

My Account

Information

Access Key